Boucher CA - Search Results

1

Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain.

Rokx C, Richman DD, Müller-Trutwin M, Silvestri G, Lunzen J, Khoo S, Lichterfeld M, Altfeld M, Perno CF, Hunt PW, Mallon P, Rockstroh JK, Pozniak AL, Clotet B, Boucher CA. Rokx C, et al. Among authors: boucher ca. J Virus Erad. 2015 Jul 1;1(3):211-20. doi: 10.1016/S2055-6640(20)30497-0. J Virus Erad. 2015. PMID: 27482415 Free PMC article.

2

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

Tural C, Ruiz L, Holtzer C, Schapiro J, Viciana P, González J, Domingo P, Boucher C, Rey-Joly C, Clotet B; Havana Study Group. Tural C, et al. AIDS. 2002 Jan 25;16(2):209-18. doi: 10.1097/00002030-200201250-00010. AIDS. 2002. PMID: 11807305 Clinical Trial.

3

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.

Martinez-Picado J, Negredo E, Ruiz L, Shintani A, Fumaz CR, Zala C, Domingo P, Vilaró J, Llibre JM, Viciana P, Hertogs K, Boucher C, D'Aquila RT, Clotet B; SWATCH Study Team. Martinez-Picado J, et al. Ann Intern Med. 2003 Jul 15;139(2):81-9. doi: 10.7326/0003-4819-139-2-200307150-00007. Ann Intern Med. 2003. PMID: 12859157 Clinical Trial.

4

The XIVth International HIV Drug Resistance Workshop, Quebec City, Canada, June 2005.

Boucher C, Larder B, Mellors J, Richman D. Boucher C, et al. Antivir Ther. 2006;11(5):653-65. Antivir Ther. 2006. PMID: 16964836

5

Key reports from the XV International HIV Drug Resistance Workshop 2006.

Mascolini M, Boucher C, Larder B, Mellors J, Richman D. Mascolini M, et al. Antivir Ther. 2007;12(1):131-45. Antivir Ther. 2007. PMID: 17503758

6

Clinical implications of resistance to antiretrovirals: new resistance technologies and interpretations.

Mascolini M, Richman D, Larder B, Mellors J, Boucher CA. Mascolini M, et al. Among authors: boucher ca. Antivir Ther. 2008;13(2):319-34. Antivir Ther. 2008. PMID: 18505183

7

Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop.

Mascolini M, Larder BA, Boucher CA, Richman DD, Mellors JW. Mascolini M, et al. Among authors: boucher ca. Antivir Ther. 2008;13(8):1097-113. Antivir Ther. 2008. PMID: 19195337

8

Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop.

Mascolini M, Boucher CA, Mellors JW, Larder BA, Richman DD. Mascolini M, et al. Among authors: boucher ca. Antivir Ther. 2009;14(7):1015-37. doi: 10.3851/IMP1423. Antivir Ther. 2009. PMID: 19918107

9

HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies.

Mascolini M, Mellors JW, Richman DD, Boucher CA, Larder BA. Mascolini M, et al. Among authors: boucher ca. Antivir Ther. 2011;16(2):263-86. doi: 10.3851/IMP1761. Antivir Ther. 2011. PMID: 21447877

10

Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network.

Pillay D, Albert J, Bertagnolio S, Boucher C, Brun-Vezinet F, Clotet B, Giaquinto C, Perno CF. Pillay D, et al. Antivir Ther. 2013;18(6):831-6. doi: 10.3851/IMP2650. Epub 2013 Jun 5. Antivir Ther. 2013. PMID: 23740717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

505 results

Search Page

Filters